InvestorsHub Logo

Alyssa

02/29/20 1:34 PM

#176608 RE: xoc #176567

Thank you for this interesting article. As you must know, Arrayit has already participated in research and development of microarray rapid testing for Zika, Hepatitis A, H1N1 Swine Flu, Dengue Virus, Human norovirus, E. Coli and other bacterial/foodborne pathogens, and probably more, working with places like Johns Hopkins and the USDA.

What a great thing for the world if rapid testing for the coronavirus could be made available by Arrayit, especially since their home state of California has more cases than other US states, and from what I have read testing kits and resources are extremely limited.

bgrass1

02/29/20 1:39 PM

#176609 RE: xoc #176567

Thanks for posting this article.

It is clear indication that ARYC is rapidly becoming an also ran in this field before even starting, as the competition grows and surges past ARYC.

Very bad news for ARYC and it’s long suffering shareholders.

Live and learn.